Vimarsana
Biggest News Aggregation in the World

Page 20 - Cell Line Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Line Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Line Development Today - Breaking & Trending Today

Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen's AGE1.CR® Vaccine Manufacturing Platform - Vimarsana News

Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen's AGE1.CR® Vaccine Manufacturing Platform

BERLIN, Germany and NEW YORK, USA, January 06, 2022 / B3C newswire / -- ProBioGen AG is delighted to announce the execution of a service and commercial product license agreement with Imvaq Therapeutics, a biotech company developing innovative cancer immunotherapies. Under this agreement, ProBioGen develops a scalabl...

2021 Insights on Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies - - Vimarsana News

2021 Insights on Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies -

DUBLIN--(BUSINESS WIRE)--The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added to ResearchAndMarkets.com's offering.The publisher's research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturin...

Bioprocess Technology Market will Reach Revenues Worth US$ 78.8 Billion by 2031 - Vimarsana News

Bioprocess Technology Market will Reach Revenues Worth US$ 78.8 Billion by 2031

Bioprocess technology market valuation is anticipated to expand at a CAGR 14.8% over the forecast period of 2021 to 2031, as per the latest study by Fact.MR, a market research and competitive intelligence provider. Demand for bioprocess engineering in biotechnology is set to be valued at around US$ 78.8 Bn by 2031-e...

Sartorius strengthens its bioanalytics portfolio - Vimarsana News

Sartorius strengthens its bioanalytics portfolio

Sartorius acquires a majority stake in ALS Automated Lab Solutions

Sartorius strengthens its bioanalytics portfolio - Vimarsana News

Sartorius strengthens its bioanalytics portfolio

Sartorius acquires a majority stake in ALS Automated Lab Solutions